Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IFNK Protein (AA 24-195) (His tag)

IFNK Origine: Boeuf (Vache) Hôte: Escherichia coli (E. coli) Recombinant > 90 % SDS
N° du produit ABIN5710800
  • Antigène Tous les produits IFNK
    IFNK (Interferon, kappa (IFNK))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 24-195
    Origine
    • 4
    • 1
    Boeuf (Vache)
    Source
    • 2
    • 2
    • 1
    Escherichia coli (E. coli)
    Purification/Conjugué
    Cette IFNK protéine est marqué à la His tag.
    Application
    SDS-PAGE (SDS)
    Séquence
    CYLSEDHMLG ARENLRLLAR MNRLSPHPCL QDRKDFGLPQ EMVEGNQLQK DQAISVLHEM LQQCFNLFYT EHSSAAWNTT LLEQLCTGLQ QQLEDLDACL GPVMGEKDSD MGRMGPILTV KKYFQGIHVY LKEKEYSDCA WEIIRVEMMR ALSSSTTLQK RLRKMGGDLN SL
    Purification
    SDS-PAGE
    Pureté
    > 90 %
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.1-2 mg/mL
    Buffer
    20 mM Tris-HCl based buffer, pH 8.0
    Stock
    -80 °C,4 °C,-20 °C
    Stockage commentaire
    Store at -20°C, for extended storage, conserve at -20°C or -80°C. Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
  • Antigène
    IFNK (Interferon, kappa (IFNK))
    Autre désignation
    IFNT1 (IFNK Produits)
    Synonymes
    IFNK Protein, IFNT1 Protein, INFE1 Protein, RP11-27J8.1 Protein, interferon kappa Protein, IFNK Protein, Ifnk Protein
    Sujet
    Paracrine hormone primarily responsible for maternal recognition of pregnancy. Interacts with endometrial receptors, probably type I interferon receptors, and blocks estrogen receptor expression, preventing the estrogen-induced increase in oxytocin receptor expression in the endometrium. This results in the suppression of the pulsatile endometrial release of the luteolytic hormone prostaglandin F2-alpha, hindering the regression of the corpus luteum (luteolysis) and therefore a return to ovarian cyclicity. This, and a possible direct effect of IFN-tau on prostaglandin synthesis, leads in turn to continued ovarian progesterone secretion, which stimulates the secretion by the endometrium of the nutrients required for the growth of the conceptus. In summary, displays particularly high antiviral and antiproliferative potency concurrently with particular weak cytotoxicity, high antiluteolytic activity and immunomodulatory properties. In contrast with other IFNs, IFN-tau is not virally inducible.
    Poids moléculaire
    23.8 kDa
    UniProt
    P15696
Vous êtes ici:
Support technique